IP Group PLC (IPO.L)

IPO.L on London Stock Exchange

221.40GBp
9:05pm IST
Change (% chg)

-2.20p (-0.98%)
Prev Close
223.60p
Open
217.00p
Day's High
226.20p
Day's Low
217.00p
Volume
171,355
Avg. Vol
300,031
52-wk High
276.78p
52-wk Low
173.52p

IPO.L

Chart for IPO.L

About

IP Group plc (IP Group) is a United Kingdom-based company that develops intellectual property-based businesses. The Company operates through three business segments: University partnership business, Venture capital fund management and In-licensing activity. The Company's University partnership business segment is engaged in the... (more)

Overall

Beta: 1.03
Market Cap(Mil.): £1,262.49
Shares Outstanding(Mil.): 564.62
Dividend: --
Yield (%): --

Financials

Search Stocks

BRIEF-IP Group's portfolio company First Light Fusion completes 22.7 mln stg funding round

* IP Group Plc - portfolio company First Light Fusion completes 22.7 mln stg funding round

14 Aug 2015

BUZZ-IP Group: among top UK midcaps after strong results

** IP Group, an intellectual property marketing co, up c.3.4 pct & features among top FTSE-250 gainers

05 Aug 2015

BRIEF-Patent marketing firm IP Group's H1 adjusted pretax profit 70.1 mln stg vs 15 mln stg

* Net assets excluding intangibles and Oxford equity rights asset increased to 700.6 mln stg (HY14: 449.4 mln stg; FY14: 451.3 mln stg)

05 Aug 2015

BRIEF-IP Group's portfolio company Oxford Nanopore raises 70 mln stg

* Portfolio company oxford nanopore announces 70 mln stg fundraising

21 Jul 2015

BRIEF-Patent marketing firm IP Group secures 30 mln stg debt facility

* IP Group Plc - secures 30 mln stg, 8-year debt facility from European Investment Bank

09 Jul 2015

BRIEF-IP Group says to take stake in Oxford Sciences Innovation

* Will have an initial beneficial equity stake of 17.9 percent in OSI after committing £40 million of funding

14 May 2015

BRIEF-IP Group says portfolio now consists of holdings in 93 intellectual property-based cos

* Says as at 8 May 2015, fair value of group's portfolio was £385.0m compared to £349.9m at 31 December 2014. Source text for Eikon: Further company coverage:

12 May 2015

BRIEF-IP Group says U.S. FDA grants portfolio co's Chronocort orphan drug designation

* Portfolio company Diurnal Limited granted orphan drug designation in U.S. Source text for Eikon: Further company coverage:

25 Mar 2015

BRIEF-IP Group to raise about 128 mln stg via firm placing

* Announces a share issue to raise gross proceeds of approximately gbp 128.0 million (approximately gbp 124.7 million net of expenses) through issue of 56,888,888 capital raising shares by way of a firm placing

10 Mar 2015

Earnings vs. Estimates

Search Stocks